Meeder Asset Management Inc. trimmed its holdings in MeiraGTx Holdings PLC (NASDAQ:MGTX) by 25.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,485 shares of the company’s stock after selling 849 shares during the quarter. Meeder Asset Management Inc.’s holdings in MeiraGTx were worth $50,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also made changes to their positions in MGTX. Focused Wealth Management Inc increased its holdings in MeiraGTx by 39.3% during the 4th quarter. Focused Wealth Management Inc now owns 2,125 shares of the company’s stock worth $43,000 after purchasing an additional 600 shares in the last quarter. Bank of Montreal Can increased its holdings in MeiraGTx by 42.6% during the 4th quarter. Bank of Montreal Can now owns 2,142 shares of the company’s stock worth $43,000 after purchasing an additional 640 shares in the last quarter. Tower Research Capital LLC TRC bought a new stake in MeiraGTx during the 3rd quarter worth approximately $72,000. Citigroup Inc. increased its holdings in MeiraGTx by 643.9% during the 4th quarter. Citigroup Inc. now owns 6,308 shares of the company’s stock worth $126,000 after purchasing an additional 5,460 shares in the last quarter. Finally, Victory Capital Management Inc. increased its holdings in MeiraGTx by 108.8% during the 4th quarter. Victory Capital Management Inc. now owns 7,021 shares of the company’s stock worth $141,000 after purchasing an additional 3,659 shares in the last quarter. 45.28% of the stock is currently owned by institutional investors.
MGTX has been the subject of a number of recent research reports. BidaskClub raised MeiraGTx from a “sell” rating to a “hold” rating in a report on Thursday. ValuEngine raised MeiraGTx from a “hold” rating to a “buy” rating in a report on Friday, March 6th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $40.00 target price on shares of MeiraGTx in a report on Monday, December 16th. Zacks Investment Research raised MeiraGTx from a “hold” rating to a “strong-buy” rating and set a $11.00 target price for the company in a report on Wednesday, March 18th. Finally, Chardan Capital reaffirmed a “buy” rating and issued a $45.00 target price on shares of MeiraGTx in a report on Sunday. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $31.50.
MeiraGTx stock traded up $0.99 during trading on Thursday, hitting $13.05. The stock had a trading volume of 5,581 shares, compared to its average volume of 137,071. MeiraGTx Holdings PLC has a 1 year low of $8.82 and a 1 year high of $30.23. The company has a quick ratio of 5.47, a current ratio of 5.47 and a debt-to-equity ratio of 0.11. The stock’s 50 day moving average is $15.88 and its two-hundred day moving average is $17.43. The stock has a market cap of $444.05 million, a price-to-earnings ratio of -7.75 and a beta of 2.11.
MeiraGTx (NASDAQ:MGTX) last posted its quarterly earnings data on Wednesday, March 11th. The company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.52) by $0.40. MeiraGTx had a negative return on equity of 33.20% and a negative net margin of 411.84%. The business had revenue of $6.94 million for the quarter, compared to the consensus estimate of $0.70 million. As a group, equities research analysts anticipate that MeiraGTx Holdings PLC will post -2.06 EPS for the current fiscal year.
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson's diseases.
Further Reading: Death Cross
Want to see what other hedge funds are holding MGTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MeiraGTx Holdings PLC (NASDAQ:MGTX).
Receive News & Ratings for MeiraGTx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MeiraGTx and related companies with MarketBeat.com's FREE daily email newsletter.